COMMUNIQUÉS West-GlobeNewswire

Nusano Receives “Best Companies to Work For” Award from Utah Business
11/12/2025
State’s top workplaces identified by employee survey data WEST VALLEY CITY, Utah, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Nusano, physics company working to transform radioisotope production and enable industries ranging from [...]
Tenaya Therapeutics Announces Proposed Public Offering
11/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
11/12/2025
Phase 3 study builds on positive phase 2 results showing rapid and sustained reductions in key disease biomarkers and clinical measures of CAH SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc [...]
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
11/12/2025
WALTHAM, Mass., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today [...]
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/12/2025
FOSTER CITY, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced the closing of its previously announced [...]
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
11/12/2025
HUNTSVILLE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ("IND") [...]
FDA Approves the Zenflow Spring® Implant and Delivery System for First-Line Interventional Therapy of Patients with Benign Prostatic Hyperplasia (BPH)
11/12/2025
Long-Term Data Supports Three-Year Durability Innovative Design Allows for Only Tailored BPH Approach that Preserves Natural Anatomy SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc . [...]
The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California
11/12/2025
Southeast Buyers are Existing Members of the Franchise Community, Further Increasing their Ownership SCOTTSDALE, Ariz., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor [...]
Microbix Schedules Release of Results for Q4 Fiscal 2025
11/12/2025
Results Release and Webinar Discussion on Morning of December 18, 2025 MISSISSAUGA, Ontario, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, [...]
Cycle Pharmaceuticals to Acquire Applied Therapeutics
11/12/2025
Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- [...]
California Provider Organizations Earn Recognition from IHA for Healthcare Performance
11/12/2025
The Integrated Healthcare Association’s Align. Measure. Perform. program celebrates top-performing and most-improved providers. OAKLAND, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Integrated Healthcare Association ( [...]
Changes to the Executive Management
11/12/2025
December 11, 2025 Announcement no. 29 Changes to the Executive Management COPENHAGEN, DENMARK and BOSTON, MA, USA, December 11, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto”) (CPH:BIOPOR) announced today that Niels [...]
AB Science annonce une nouvelle publication sur Medrxiv mettant en évidence le bénéfice clinique du masitinib chez les patients atteints de Sclérose Latérale Amyotrophique avant toute perte complète de fonction
11/12/2025
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE UNE NOUVELLE PUBLICATION SUR MEDRXIV METTANT EN ÉVIDENCE LE BÉNÉFICE CLINIQUE DU MASITINIB CHEZ LES PATIENTS ATTEINTS DE SCLÉROSE LATÉRALE AMYOTROPHIQUE AVANT TOUTE PERTE COMPLÈTE [...]
AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function
11/12/2025
PRESS RELEASE AB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS PRIOR ANY COMPLETE LOSS OF FUNCTION Significant improvement in [...]
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
11/12/2025
CHICAGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Ateganosine (THIO, 6-thio-2'-deoxyguanosine), a first-in-class telomere-targeting therapy under development by MAIA Biotechnology (NYSE American: MAIA), appears to be gaining [...]
Hundreds Gather in Seattle in Support of Increasing Access to Mental Health Services in King County at SOUND Behavioral Health’s Annual SOUND of Hope Gala
11/12/2025
Second Annual Gala Fundraiser Exceeds SOUND’s Fundraising Goal to Help Open More Doors to Mental Health and Substance Abuse Services SEATTLE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In late November more than 400 community [...]
SEMCAP Health Leads $25 Million Series D Investment in SafeinHome
11/12/2025
WALNUT CREEK, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- SafeinHome , the nation’s leader in Remote Supports for individuals with intellectual and developmental disabilities (I/DD), today announced the successful first [...]
Merakris Therapeutics Chief Scientific Officer Dr. Roger Ilagan to Present at Innovations in Wound Healing Symposium
11/12/2025
RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a regenerative medicine company developing biologic drug therapies for hard-to-heal wounds, announces that Chief Scientific Officer [...]

Pages